Investing.com - Selecta Bio reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Selecta Bio announced earnings per share of $-0.050 on revenue of $20.71M. Analysts polled by Investing.com EPS of $-0.006 on revenue of $24.64M.
Selecta Bio 's are down 49% and is trading at $1.640 , still down 62.25% from its 52 week high of $4.34 set on Monday, November 8, 2021.
Selecta Bio follows other major Healthcare sector earnings this month
Selecta Bio's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar